Loading...

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes

Janumet(TM,) a fixed dose combination of sitagliptin/metformin HCL manufactured by Merck Pharmaceuticals, has received US Food and Drug Administration approval for treatment of patients with type 2 diabetes, that are inadequately controlled, either by sitagliptin or metformin alone or together in fr...

Full description

Saved in:
Bibliographic Details
Main Author: Reynolds, Jonathan K
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2009
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048013/
https://ncbi.nlm.nih.gov/pubmed/21437126
Tags: Add Tag
No Tags, Be the first to tag this record!